Logo image of CMB.MI

CEMBRE SPA (CMB.MI) Stock Fundamental Analysis

Europe - BIT:CMB - IT0001128047 - Common Stock

52 EUR
-2.1 (-3.88%)
Last: 9/23/2025, 7:00:00 PM
Fundamental Rating

7

CMB gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Electrical Equipment industry. CMB gets an excellent profitability rating and is at the same time showing great financial health properties. CMB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CMB had positive earnings in the past year.
In the past year CMB had a positive cash flow from operations.
Each year in the past 5 years CMB has been profitable.
Each year in the past 5 years CMB had a positive operating cash flow.
CMB.MI Yearly Net Income VS EBIT VS OCF VS FCFCMB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

1.2 Ratios

With an excellent Return On Assets value of 22.19%, CMB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CMB has a better Return On Equity (30.90%) than 98.41% of its industry peers.
The Return On Invested Capital of CMB (29.30%) is better than 98.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMB is significantly above the industry average of 9.51%.
The 3 year average ROIC (18.10%) for CMB is below the current ROIC(29.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.19%
ROE 30.9%
ROIC 29.3%
ROA(3y)15.11%
ROA(5y)12.91%
ROE(3y)18.73%
ROE(5y)16.43%
ROIC(3y)18.1%
ROIC(5y)16.11%
CMB.MI Yearly ROA, ROE, ROICCMB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CMB has a better Profit Margin (18.65%) than 98.41% of its industry peers.
CMB's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 24.09%, CMB belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
CMB's Operating Margin has improved in the last couple of years.
CMB has a better Gross Margin (70.10%) than 92.06% of its industry peers.
CMB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.09%
PM (TTM) 18.65%
GM 70.1%
OM growth 3Y3.91%
OM growth 5Y4.36%
PM growth 3Y6.9%
PM growth 5Y4.57%
GM growth 3Y0.43%
GM growth 5Y0.07%
CMB.MI Yearly Profit, Operating, Gross MarginsCMB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CMB is creating value.
Compared to 1 year ago, CMB has about the same amount of shares outstanding.
Compared to 5 years ago, CMB has more shares outstanding
The debt/assets ratio for CMB is higher compared to a year ago.
CMB.MI Yearly Shares OutstandingCMB.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CMB.MI Yearly Total Debt VS Total AssetsCMB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CMB has an Altman-Z score of 10.13. This indicates that CMB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 10.13, CMB belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
The Debt to FCF ratio of CMB is 2.23, which is a good value as it means it would take CMB, 2.23 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.23, CMB belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
CMB has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CMB (0.04) is better than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.23
Altman-Z 10.13
ROIC/WACC3.6
WACC8.14%
CMB.MI Yearly LT Debt VS Equity VS FCFCMB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

CMB has a Current Ratio of 2.21. This indicates that CMB is financially healthy and has no problem in meeting its short term obligations.
CMB has a Current ratio of 2.21. This is in the better half of the industry: CMB outperforms 77.78% of its industry peers.
A Quick Ratio of 1.09 indicates that CMB should not have too much problems paying its short term obligations.
The Quick ratio of CMB (1.09) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.09
CMB.MI Yearly Current Assets VS Current LiabilitesCMB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.86% over the past year.
CMB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.46% yearly.
The Revenue has been growing slightly by 3.52% in the past year.
CMB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.44% yearly.
EPS 1Y (TTM)15.86%
EPS 3Y18.82%
EPS 5Y14.46%
EPS Q2Q%8.44%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y11.25%
Revenue growth 5Y9.44%
Sales Q2Q%3.98%

3.2 Future

CMB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.09% yearly.
CMB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.28% yearly.
EPS Next Y15.84%
EPS Next 2Y10.31%
EPS Next 3Y-11.09%
EPS Next 5YN/A
Revenue Next Year6.2%
Revenue Next 2Y6.12%
Revenue Next 3Y6.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMB.MI Yearly Revenue VS EstimatesCMB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CMB.MI Yearly EPS VS EstimatesCMB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.54 indicates a correct valuation of CMB.
90.48% of the companies in the same industry are more expensive than CMB, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.41. CMB is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 18.35, which indicates a rather expensive current valuation of CMB.
Based on the Price/Forward Earnings ratio, CMB is valued a bit cheaper than 66.67% of the companies in the same industry.
CMB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 13.54
Fwd PE 18.35
CMB.MI Price Earnings VS Forward Price EarningsCMB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMB is valued a bit cheaper than 73.02% of the companies in the same industry.
CMB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 49.07
EV/EBITDA 9.68
CMB.MI Per share dataCMB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CMB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CMB may justify a higher PE ratio.
A cheap valuation may be justified as CMB's earnings are expected to decrease with -11.09% in the coming years.
PEG (NY)0.86
PEG (5Y)0.94
EPS Next 2Y10.31%
EPS Next 3Y-11.09%

6

5. Dividend

5.1 Amount

CMB has a Yearly Dividend Yield of 3.47%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.14, CMB pays a better dividend. On top of this CMB pays more dividend than 92.06% of the companies listed in the same industry.
CMB's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.47%

5.2 History

On average, the dividend of CMB grows each year by 14.86%, which is quite nice.
Dividend Growth(5Y)14.86%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

48.95% of the earnings are spent on dividend by CMB. This is a bit on the high side, but may be sustainable.
DP48.95%
EPS Next 2Y10.31%
EPS Next 3Y-11.09%
CMB.MI Yearly Income VS Free CF VS DividendCMB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
CMB.MI Dividend Payout.CMB.MI Dividend Payout, showing the Payout Ratio.CMB.MI Dividend Payout.PayoutRetained Earnings

CEMBRE SPA

BIT:CMB (9/23/2025, 7:00:00 PM)

52

-2.1 (-3.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)09-12 2025-09-12
Earnings (Next)11-14 2025-11-14
Inst Owners13.99%
Inst Owner ChangeN/A
Ins Owners17.89%
Ins Owner ChangeN/A
Market Cap884.00M
Analysts47.5
Price Target51 (-1.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.47%
Yearly Dividend1.8
Dividend Growth(5Y)14.86%
DP48.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 13.54
Fwd PE 18.35
P/S 2.55
P/FCF 49.07
P/OCF 19.25
P/B 4.23
P/tB 4.43
EV/EBITDA 9.68
EPS(TTM)3.84
EY7.38%
EPS(NY)2.83
Fwd EY5.45%
FCF(TTM)1.06
FCFY2.04%
OCF(TTM)2.7
OCFY5.19%
SpS20.37
BVpS12.3
TBVpS11.73
PEG (NY)0.86
PEG (5Y)0.94
Profitability
Industry RankSector Rank
ROA 22.19%
ROE 30.9%
ROCE 37.79%
ROIC 29.3%
ROICexc 31.62%
ROICexgc 33.15%
OM 24.09%
PM (TTM) 18.65%
GM 70.1%
FCFM 5.2%
ROA(3y)15.11%
ROA(5y)12.91%
ROE(3y)18.73%
ROE(5y)16.43%
ROIC(3y)18.1%
ROIC(5y)16.11%
ROICexc(3y)20.33%
ROICexc(5y)20.99%
ROICexgc(3y)21.37%
ROICexgc(5y)22.45%
ROCE(3y)23.12%
ROCE(5y)20.57%
ROICexcg growth 3Y-14.75%
ROICexcg growth 5Y5.69%
ROICexc growth 3Y-13.07%
ROICexc growth 5Y6.06%
OM growth 3Y3.91%
OM growth 5Y4.36%
PM growth 3Y6.9%
PM growth 5Y4.57%
GM growth 3Y0.43%
GM growth 5Y0.07%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.23
Debt/EBITDA 0.08
Cap/Depr 201.99%
Cap/Sales 8.06%
Interest Coverage 250
Cash Conversion 47.22%
Profit Quality 27.9%
Current Ratio 2.21
Quick Ratio 1.09
Altman-Z 10.13
F-Score5
WACC8.14%
ROIC/WACC3.6
Cap/Depr(3y)146.17%
Cap/Depr(5y)118%
Cap/Sales(3y)8.53%
Cap/Sales(5y)7.36%
Profit Quality(3y)53.16%
Profit Quality(5y)75.45%
High Growth Momentum
Growth
EPS 1Y (TTM)15.86%
EPS 3Y18.82%
EPS 5Y14.46%
EPS Q2Q%8.44%
EPS Next Y15.84%
EPS Next 2Y10.31%
EPS Next 3Y-11.09%
EPS Next 5YN/A
Revenue 1Y (TTM)3.52%
Revenue growth 3Y11.25%
Revenue growth 5Y9.44%
Sales Q2Q%3.98%
Revenue Next Year6.2%
Revenue Next 2Y6.12%
Revenue Next 3Y6.28%
Revenue Next 5YN/A
EBIT growth 1Y12.66%
EBIT growth 3Y15.6%
EBIT growth 5Y14.22%
EBIT Next Year42.86%
EBIT Next 3Y17.88%
EBIT Next 5YN/A
FCF growth 1Y-21.3%
FCF growth 3Y-14.59%
FCF growth 5Y-5.79%
OCF growth 1Y21.35%
OCF growth 3Y8.96%
OCF growth 5Y6.26%